Experts examine regulation for nanotech industry

07/29/2008 | Forbes

A panel of experts recently touted the potential of nanotechnology, but cited several market uncertainties for the industry, especially around increased oversight. J. Clarence Davies of the Project on Emerging Nanotechnologies at the Woodrow Wilson Center released a regulatory agenda for the next presidential administration that says regulation is inevitable, but that it could help the nanotech market, particularly in attracting investors.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Senior Counsel – Regulatory Affairs
RAI Services Company
Winston-Salem, NC